All News

A three-time survivor stresses second opinions, therapy and caregiver self-care to help patients navigate treatment, recovery and life after surgery.

My intent in writing this blog is to make sure that other people whose loved ones have cancer understand just how amazing it is to be given short respites from being a patient.

Six-time cancer survivor encourages patients to trust doctors, lean on support, and save energy for moving forward instead of fear.

The U.S. FDA has granted orphan drug designation to HCB101, an investigational immunotherapy, for the treatment of gastric cancer.

There are a number of pulmonary embolism warning signs patients with cancer and their caregivers should watch for.

Phase 2 study shows proton therapy kept 79.1% of patients progression free at five years and limited severe side effects compared with older radiation data.

Exploring the importance of heart health in cancer survivorship, we spoke with experts and survivors.

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment.

A liver cancer survivor shares transplant insights, dispels living donor myths and urges patients to advocate for informed, hopeful care.

A three-time cervical cancer survivor urges patients with cancer to be thorough, seek multiple opinions and trust their gut to find providers who listen, validate concerns and truly support them.

Dr. Sue Hwang, a radiation oncologist and breast cancer survivor, sheds light on the reality of cancer survivorship.

A Clayman Thyroid Center report aims to clarify FDA safety warnings, finding no evidence that GLP-1 drugs like Ozempic cause common thyroid cancers.

The FDA has accepted a sNDA for Ameluz topical gel, used in combination with the RhodoLED red-light lamp series, for superficial basal cell carcinoma treatment.

The U.S. Food and Drug Administration has approved a new treatment for adults with locally advanced pancreatic cancer.

Colleen Mabasa reflected on the importance of self-advocacy, as well as seeking second opinions and ensuring patients understand all available options.

At Triage Cancer, we’re here to help you understand your options, protect your rights, and move forward with clarity and confidence.

Riozzi Bodine shares how her daughter’s diagnosis inspired the launch of a foundation offering cold caps, wigs and caregiver support.

A nurse practitioner explains how FDA approval of subcutaneous Rybrevant may reduce treatment burden and improve care for patients with EGFR-mutated lung cancer.

New research shows specific chemotherapies and radiation increase the risk of subsequent brain tumors in long-term childhood cancer survivors.

Showing up taking notes and learning the disease can help families feel empowered as new treatments expand hope and quality of life.

Laura Yeager reflects on losses from theft and cancer, showing how resilience grows and gratitude emerges even after life's hardest setbacks.

CURE spoke with a provider and a survivor about the potential power of minimal residual disease testing.

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive Keytruda.

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use with JAK inhibitors.

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

FDA OKs Keytruda with paclitaxel for PD-L1 positive, platinum-resistant ovarian, fallopian tube or peritoneal cancers, improving survival and delaying growth.

Charles Walker joins CURE’s Gina Mauro to share his long and road to a liver cancer diagnosis and the importance of being your own medical advocate.